We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Technology Helps Monitor Brain Aneurysm Treatment

By HospiMedica International staff writers
Posted on 29 Nov 2011
An approach that is potentially less invasive and more accurate for monitoring brain aneurysms is also simple enough for patients to use at home for frequent monitoring.

Researchers at the University of British Columbia (UBC; Vancouver, Canada) developed the new wireless monitoring technique for cerebral aneurysms by using the implanted Guglielmi Detachable Coil (GDC) embolization coils themselves as radiofrequency (RF) resonant sensors that detect blood entry. More...
As the blood flows into a coil-implanted aneurysm, the parasitic capacitance of the coil is modified due to the difference in permittivity between the blood and the tissues grown around the coil, resulting in a change in the coil's resonant frequency.

The resonances of platinum GDC-like coils embedded in aneurysm models were shown to generate average responses of 224-819 MHz/mL to saline injected into them in laboratory models. The preliminary demonstration indicates a possible first step toward realizing long-term, noninvasive, and cost-effective remote monitoring of cerebral aneurysms treated with GDC embolization. The study was published ahead of print on October 15, 2011, in Biosensors and Bioelectronics.

“This is a completely brand new approach to monitoring cerebral embolization and our tests in the lab have been quite successful,” said lead author Kenichi Takahata, PhD, an assistant professor in the department of electrical and computer engineering. “As an early detection method, what we're proposing could be carried out by patients at home on a continual basis. We anticipate having a prototype within two to three years.”

Currently, the only way to check whether an embolization is still working is to expose patients to high-dose X-rays for a computerized tomography (CT) scan or angiography, an invasive procedure that involves using catheters to inject dyes needed to highlight brain arteries. Both methods preclude frequent patient checkups.

Related Links:

University of British Columbia



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.